Evidence map›Paper›PMID 36918196›Full record

ArticleJournal of psychiatry & neuroscience : JPN

Metformin for the treatment of antipsychotic-induced metabolic disturbances in people with intellectual and developmental disabilities.

Nicolette Stogios, Margaret K Hahn, Yona Lunsky, Pushpal Desarkar, Sri Mahavir Agarwal

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of psychiatry & neuroscience : JPN. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Medication-Induced Hyperglycemia and Diabetes Mellitus: A Review of Current Literature and Practical Management Strategies.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2024
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Nicolette StogiosFrom the Institute of Medical Science, University of Toronto, Toronto, Ont. (Stogios, Hahn, Desarkar, Agarwal); the Schizophrenia Division, Centre for Addiction and Mental Health, Toronto, Ont. (Stogios, Hahn, Agarwal); the Department of Psychiatry, University of Toronto, Toronto, Ont. (Hahn, Lunsky, Desarkar, Agarwal); the Banting and Best Diabetes Centre, University of Toronto, Toronto, Ont. (Hahn, Agarwal); the Azrieli Adult Neurodevelopmental Centre, Centre for Addiction and Mental Health, Toronto, Ont. (Lunsky, Desarkar).
Margaret K HahnFrom the Institute of Medical Science, University of Toronto, Toronto, Ont. (Stogios, Hahn, Desarkar, Agarwal); the Schizophrenia Division, Centre for Addiction and Mental Health, Toronto, Ont. (Stogios, Hahn, Agarwal); the Department of Psychiatry, University of Toronto, Toronto, Ont. (Hahn, Lunsky, Desarkar, Agarwal); the Banting and Best Diabetes Centre, University of Toronto, Toronto, Ont. (Hahn, Agarwal); the Azrieli Adult Neurodevelopmental Centre, Centre for Addiction and Mental Health, Toronto, Ont. (Lunsky, Desarkar).
Yona LunskyFrom the Institute of Medical Science, University of Toronto, Toronto, Ont. (Stogios, Hahn, Desarkar, Agarwal); the Schizophrenia Division, Centre for Addiction and Mental Health, Toronto, Ont. (Stogios, Hahn, Agarwal); the Department of Psychiatry, University of Toronto, Toronto, Ont. (Hahn, Lunsky, Desarkar, Agarwal); the Banting and Best Diabetes Centre, University of Toronto, Toronto, Ont. (Hahn, Agarwal); the Azrieli Adult Neurodevelopmental Centre, Centre for Addiction and Mental Health, Toronto, Ont. (Lunsky, Desarkar).
Pushpal DesarkarFrom the Institute of Medical Science, University of Toronto, Toronto, Ont. (Stogios, Hahn, Desarkar, Agarwal); the Schizophrenia Division, Centre for Addiction and Mental Health, Toronto, Ont. (Stogios, Hahn, Agarwal); the Department of Psychiatry, University of Toronto, Toronto, Ont. (Hahn, Lunsky, Desarkar, Agarwal); the Banting and Best Diabetes Centre, University of Toronto, Toronto, Ont. (Hahn, Agarwal); the Azrieli Adult Neurodevelopmental Centre, Centre for Addiction and Mental Health, Toronto, Ont. (Lunsky, Desarkar).
Sri Mahavir AgarwalFrom the Institute of Medical Science, University of Toronto, Toronto, Ont. (Stogios, Hahn, Desarkar, Agarwal); the Schizophrenia Division, Centre for Addiction and Mental Health, Toronto, Ont. (Stogios, Hahn, Agarwal); the Department of Psychiatry, University of Toronto, Toronto, Ont. (Hahn, Lunsky, Desarkar, Agarwal); the Banting and Best Diabetes Centre, University of Toronto, Toronto, Ont. (Hahn, Agarwal); the Azrieli Adult Neurodevelopmental Centre, Centre for Addiction and Mental Health, Toronto, Ont. (Lunsky, Desarkar).
University of Toronto · CADiabetes Canada · CA

Funding

CIHR PJT-153262
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antipsychotic AgentsMetforminChildDevelopmental DisabilitiesHumansAntipsychotic AgentsMetformin

Identifiers

PMID36918196
PMCPMC10019321
OpenAlexW4324141398

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.